Compass Oncology Tualatin — Tualatin, Oregon

Compass Oncology Tualatin is a clinical research site located in Tualatin, Oregon, United States 97062.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Compass Oncology Tualatin has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative.

Sponsors: NRG Oncology.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology Tualatin?

Compass Oncology Tualatin has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology Tualatin conducted?

Compass Oncology Tualatin has 1 clinical trials on record, with 1 currently active. Their work covers Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative.

Is Compass Oncology Tualatin accredited by Crixeo Health?

Compass Oncology Tualatin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology Tualatin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.